Literature DB >> 30140853

Pregabalin and the Risk for Opioid-Related Death: A Nested Case-Control Study.

Tara Gomes1, Simon Greaves2, Wim van den Brink3, Tony Antoniou1, Muhammad M Mamdani1, J Michael Paterson4, Diana Martins5, David N Juurlink6.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 30140853     DOI： 10.7326/M18-1136

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  33 in total

1.  Medicare Formulary Coverage and Restrictions for Opioid Potentiators from 2013 to 2017.

Authors:  Aishwarya Vijay; Joseph S Ross; Nilay D Shah; Molly M Jeffery; Sanket S Dhruva
Journal:  J Gen Intern Med       Date:  2019-04       Impact factor: 5.128

2.  Retrospective Cohort Study of the Prevalence of Off-label Gabapentinoid Prescriptions in Hospitalized Medical Patients.

Authors:  Marc-Alexandre Gingras; Anthony Lieu; Louise Papillon-Ferland; Todd C Lee; Emily G McDonald
Journal:  J Hosp Med       Date:  2019-05-12       Impact factor: 2.960

3.  Patterns of pregabalin initiation and discontinuation after its subsidy in Australia.

Authors:  Tricia Chiu; Jonathan Brett; Sallie-Anne Pearson; Andrea L Schaffer
Journal:  Br J Clin Pharmacol       Date:  2020-03-22       Impact factor: 4.335

4.  Preliminary Evidence of Pregabalin Misuse among Prescription and/or Illicit Opioid (Mis)users.

Authors:  Mance E Buttram; Steven P Kurtz
Journal:  J Psychoactive Drugs       Date:  2020-02-27

5.  Thoughts on the 2019 American Academy of Sleep Medicine position statement on chronic opioid therapy and sleep.

Authors:  Gilles J Lavigne; Alberto Herrero Babiloni; Pierre Mayer; Raoul Daoust; Marc O Martel
Journal:  J Clin Sleep Med       Date:  2020-02-13       Impact factor: 4.062

6.  Often Off-label: Questionable Gabapentinoid Use Noted at Hospital Admission Warrants Deprescribing.

Authors:  Kenneth Lam; Paula A Rochon; Michael A Steinman
Journal:  J Hosp Med       Date:  2019-09       Impact factor: 2.960

7.  Prevalence of and Factors Associated with Gabapentinoid Use and Misuse Among Texas Medicaid Recipients.

Authors:  Elizabeth A Ibiloye; Jamie C Barner; Kenneth A Lawson; Karen L Rascati; Kirk E Evoy; Alyssa M Peckham
Journal:  Clin Drug Investig       Date:  2021-02-12       Impact factor: 2.859

8.  Opioid prescribing and risk of drug-opioid interactions in older discharged patients with polypharmacy in Australia.

Authors:  Aymen Ali Al-Qurain; Lemlem G Gebremichael; Mohammed S Khan; Desmond B Williams; Lorraine Mackenzie; Craig Phillips; Patrick Russell; Michael S Roberts; Michael D Wiese
Journal:  Int J Clin Pharm       Date:  2020-11-18

9.  Trends in prior receipt of prescription opioid or adjuvant analgesics among patients with incident opioid use disorder or opioid-related overdose from 2006 to 2016.

Authors:  Yu-Jung Jenny Wei; Cheng Chen; Siegfried O Schmidt; Wei-Hsuan LoCiganic; Almut G Winterstein
Journal:  Drug Alcohol Depend       Date:  2019-09-27       Impact factor: 4.492

Review 10.  Management of Opioid-Tolerant Patients with Acute Pain: Approaching the Challenges.

Authors:  Pamela E Macintyre; Lindy J Roberts; Christine A Huxtable
Journal:  Drugs       Date:  2020-01       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.